By Dave Sherwood and Aislinn Laing

SANTIAGO (Reuters) -China’s Sinovac COVID-19 vaccine was 67% effective in preventing symptomatic infection, data from a huge real-world study in Chile has shown, a potential boost for the jab which has come under scrutiny over its level of protection against the virus.

The CoronaVac vaccine was 85% effective in preventing hospitalizations and 80% effective in preventing deaths, the Chilean government said in a report, adding that the data should prove a “game changer” from the vaccine more widely.

Rodrigo Yanez, Chile’s vice trade minister who forged a deal with Sinovac to host the drug’s clinical trial and buy 60 million doses of the drug over three years, said the results showed Chile had made “the right bet”.

“It’s a game changer for that

Read More At Article Source | Article Attribution